Literature DB >> 2680909

Antibody which defines a subset of bone marrow cells that can migrate to thymus.

H C O'Neill1.   

Abstract

A T-cell line of immature phenotype, 16C1, has been shown to have specific capacity to migrate to and localize in the thymus of irradiated mice. Several antibodies specific for the Pgp-1 molecule have been tested for their capacity to inhibit the migration of 16C1 and of bone marrow to thymus in just a 3-hr double-label migration assay. Analysis of Pgp-1 expression has revealed that 16C1, derived from C57BL mice, characteristically binds antibodies specific for the Pgp-1.1 and not the Pgp-1.2 allelic determinant, which is normally expressed by cells from C57BL mice. This unusual epitope expression has also been demonstrated for several other cell lines of similar origin to 16C1. A 5% subpopulation of C57BL bone marrow has also been defined which binds both the allele-specific antibodies. These cells exist amongst the class I+, Thy-1+, T200+ subpopulation of bone marrow. Anti-Pgp-1 antibodies have been shown to inhibit the thymus-homing capacity of both 16C1 and of bone marrow and have been used to deplete bone marrow of cells capable of reconstituting the T-cell compartment of irradiated mice. All of this indicates at least two distinct Pgp-1 determinants can be expressed by cells from C57BL mice and that antibody specific for either of these determinants can inhibit thymus homing capacity. T-cell precursors which can migrate to thymus would appear to exist amongst the subset of bone marrow cells which express both the Pgp-1.1 and Pgp-1.2 determinants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680909      PMCID: PMC1385505     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Characteristics of thymus-homing bone marrow cells.

Authors:  F Lepault; R L Coffman; I L Weissman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

2.  An in vivo assay for thymus-homing bone marrow cells.

Authors:  F Lepault; I L Weissman
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

Review 3.  The developmental biology of T lymphocytes.

Authors:  H von Boehmer
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

Review 4.  The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells.

Authors:  M J Bevan; P J Fink
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

5.  Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

Authors:  I S Trowbridge; J Lesley; R Schulte; R Hyman; J Trotter
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

6.  A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera.

Authors:  C R Parish; I F McKenzie
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

7.  Establishment, characterization and virus expression of cell lines derived from radiation- and virus-induced lymphomas of C57BL/Ka mice.

Authors:  M Lieberman; A Declève; P Ricciardi-Castagnoli; J Boniver; O J Finn; H S Kaplan
Journal:  Int J Cancer       Date:  1979-08       Impact factor: 7.396

8.  Genetic characterization of a polymorphic murine cell-surface glycoprotein.

Authors:  J Lesley; I S Trowbridge
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

9.  Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens.

Authors:  P J Fink; M J Bevan; I L Weissman
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

10.  Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes.

Authors:  I L Weissman
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  3 in total

1.  The role of CD44 in fetal and adult hematopoietic stem cell regulation.

Authors:  Huimin Cao; Shen Y Heazlewood; Brenda Williams; Daniela Cardozo; Julie Nigro; Ana Oteiza; Susan K Nilsson
Journal:  Haematologica       Date:  2015-11-06       Impact factor: 9.941

Review 2.  The clinical significance of malfunction of the CD44 locus in malignancy.

Authors:  D Tarin; J Bolodeoku; S J Hatfill; T Sugino; A C Woodman; K Yoshida
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

Review 3.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.